Better Biopharma

Better Biopharma

By Tyler MenichielloScienceLife Sciences
Download on the App Store

Better Biopharma episodes

  • Putting Pressure On CDMOs With Herman Bozenhardt

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Herman Bozenhardt, a consultant and industry veteran who has spent decades advancing the fields of biopharmaceutical manufacturing, engineering, and regulatory compliance. Bozenhardt outlines his concerns with the current outsourcing environment, noting a rising rate of noncompliance driven by poor facility maintenance and a shortage of reliable workers. He offers advice to sponsor companies working with CDMOs to help ensure their assets don’t fall victim to poor partnerships and operational mismanagement.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    57 min
  • Data Governance And Regulations For AI Use In GMP With Peter Baker

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Peter Baker, former FDA investigator and president of Live Oak Quality Assurance. They discuss Annex 22, the EMA’s GMP annex addressing the use of artificial intelligence (AI) in regulated manufacturing, including where it is sufficient and where it is lacking. Baker reflects on his time at the FDA and offers his own advice on AI and technology adoption and validation in GXP.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    45 min
  • The Editors’ Roundtable: A 2025 Retrospective Of The Life Science Industry

    In this special edition of “Better Biopharma,” host Tyler Menichiello is joined by fellow chief editors from across the Life Science Connect ecosystem to reflect on the year and share their industry outlooks for 2026. This editorial roundtable features Katie Anderson, chief editor at Pharmaceutical Online; Jeff Buguliskis, Ph.D., deputy chief editor at Outsourced Pharma; Ben Comer, chief editor at Life Science Leader and host of The Business Of Biotech podcast; Ray Dogum, chief editor at Drug Discovery Online; Erin Harris, chief editor at Cell & Gene and host of Cell & Gene: The Podcast; and Anna Rose Welch, chief editor at Advancing RNA.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    1 hr 21 min
  • Combining AI With Operations Research To Advance Biomanufacturing With Tinglong Dai, Ph.D., and Tugce Martagan, Ph.D.

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Tinglong Dai, Ph.D., Bernard T. Ferrari Professor of Business at Johns Hopkins University, and Tugce Martagan, Ph.D., associate professor at Northeastern University, to talk about the potential advancements that can be made in biomanufacturing by combining AI with operations research (OR). You can check out their recent paper on the subject, “Synergizing Artificial Intelligence And Operations Research For Advancements In Biomanufacturing,” here: https://link.springer.com/epdf/10.1007/s10729-025-09725-7?sharing_token=RsWPImKggnLuwsztf7Y1S_e4RwlQNchNByi7wbcMAY7x0AE_Vqj5xOwaldIl63JrPLRzcTIZn-7Iu6LEV-lGtfKrE2ZoADSYlnvcNAipmXCnruKMpDaS19yEPXSw9A0rbab6H57jkCX1EJOGdqO_VeCnwP3qw80LUT-QFcDzr58%3D 

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    36 min
  • Building An Oral Vaccine Platform With Vaxart's Sean Tucker, Ph.D.

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Sean Tucker, Ph.D., founder and chief scientific officer at Vaxart, a company developing oral recombinant pill vaccines. They discuss Vaxart’s manufacturing process and how it differs from traditional biopharmaceutical production, as well as the regulatory considerations around its oral vaccines.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    29 min
  • Lessons In Scaling Regenerative Medicine Manufacturing With Organogenesis's Patrick Bilbo

    In this episode of "Better Biopharma," Tyler Menichiello is joined by Patrick Bilbo, chief operating officer at Organogenesis, a regenerative medicine company developing and manufacturing advanced wound care products. They discuss the construction of Organogenesis's new facility in Rhode Island, as well as how the industry has changed in the company's 40-year history.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    44 min
  • Navigating The Complexity of Conditionally Active Biologics With Bonum Therapeutics' Diane Hollenbaugh, Ph.D., and Neela Patel, Ph.D.

    In this episode of "Better Biopharma," host Tyler Menichiello is joined by Bonum Therapeutics' chief scientific officer, Diane Hollenbaugh, Ph.D., and chief business officer, Neela Patel, Ph.D. They talk about the inherent challenges of developing complex molecules like conditionally active biologics, sharing advice on CMC strategy, analytical methodology, and working with contract manufacturing and development partners.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    48 min
  • Developing Antibodies To Block Neuroinflammation With MindImmune's Stevin Zorn, Ph.D.

    In this episode of "Better Biopharma," host Tyler Menichiello is joined by MindImmune's president and CEO, Stevin Zorn, Ph.D. They discuss the development of the company's lead candidate, MITI-101, a monoclonal antibody designed to prevent peripheral immune cells from entering the brain and driving neuroinflammation linked to Alzheimer's disease.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    45 min
  • Engineering Bacterial Vector-Based Immunotherapies With OS Therapies’ Paul Romness and Robert Petit, Ph.D.

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by OS Therapies’ CEO, Paul Romness, and chief medical and scientific officer, Robert Petit, Ph.D. The three discuss the development and manufacturing of the company’s lead asset, OST-HER2, a Listeria-based immunotherapy for osteosarcoma. They also explain the unique CMC challenges around developing a safe bacterial vector.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    37 min
  • How J&J Is Tackling Alzheimer's Disease With Fiona Elwood, Ph.D.

    In this episode of “Better Biopharma,” host Tyler Menichiello is joined by Fiona Elwood, Ph.D., VP and Neurodegeneration Disease Area Stronghold Leader at Johnson & Johnson. The two talk about J&J’s end-to-end organizational structure and its modality-agnostic approach to treating Alzheimer’s disease.

    Keep up with everything biomanufacturing at Bioprocess Online: https://www.bioprocessonline.com/

    Follow Tyler Menichiello on LinkedIn: https://www.linkedin.com/in/tmenichiello/

    Subscribe to our newsletters: https://www.bioprocessonline.com/user/edit/subscriptions

    Tell us how we can improve. Take our 60-second survey: https://docs.google.com/forms/d/e/1FAIpQLSfZGJluCmEhm1MBQvcm7_gtBEXuTx5v42LJ1mx9bCUKo8fwfg/viewform?usp=header

    33 min

About Better Biopharma

From the publisher's feed

“How can biopharma improve?” This question is the guiding ethos of the Better Biopharma podcast. Through conversations with experts across the biopharma landscape, host Tyler Menichiello…